This novel mechanism by which the downregulated miR-18b-5p is related to the regulation of several genes (Hif1α, Mef2c, miR-206, Mctp1, and Rarb) requires further investigation before it can be used for clinically meaningful application in ALS treatment. Here, MEF2C is linked to amyotrophic lateral sclerosis.